Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. DTCA/I, consumer secondary audience

DTCA/I, consumer secondary audience

84 Topics 122 Posts
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

  • All tags
  • Recently Replied
  • Recently Created
  • Most Posts
  • Most Votes
  • Most Views
Load new posts
Log in to post
  • Jennifer CarrollJ

    559 - Exactly when does a 'consumer' become a 'patient' -- is it the point at which they receive a prescription for a specific brand, or when they are dispensed a specific brand? In certain therapeutic categories (eg., epinephrine, insulin), patients receive a prescription for the molecule, which can be associated with multiple brands. At this point before a specific brand is selected, is it permissible for an HCP to expose the 'consumer/patient' to branded material, in order to facilitate brand selection? This scenario assumes that all brand options would contain the identical active molecule.

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    264 Views
    No one has replied
  • Jennifer CarrollJ

    543 - We are building a website which would contain medical information only. The website will be gated with a registration & log-in process that only allows entry to Canadian HCPs. In an effort to improve the search engine ranking of our website, we would like to optimize our website for organic search (SEO), which would include using a JavaScript log-in page that would allow search engines to crawl the pages beyond the gate. We would not offer the ability to access content on the website without registration and login validation, the purpose of allowing search engines to crawl the pages beyond the gate is simply to allow our website to appear in organic search rankings for specific key word searches. Is this permissible under the Code?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    257 Views
    No one has replied
  • Jennifer CarrollJ

    542 - Can DTC and HCP branded materials have the same headline/creative, if the DTC ad is approved by ASC and the HCP ad by PAAB? Can the DTC ad, if it is digital, link to a gated HCP portal?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    796 Views
    No one has replied
  • Jennifer CarrollJ

    540 - Hello, Suppose a vaccine product launches a branded Facebook page: The rules surrounding promotional posts are relatively clear, but what are the guidelines are on content curation? For example, including a link to an article from a publisher such as the CBC that discusses the condition but with no mention of the brand, or sharing a post from a lifestyle blog that similarly does not reference the brand/vaccine but may be relevant to followers of the page. The Health Canada policy on "The Distinction Between Advertising and Other Activities" does not seem to include this particular type of scenario explicitly. Could you provide some guidance or a link to the relevant guidelines? Thank you.

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    254 Views
    No one has replied
  • Jennifer CarrollJ

    536 - Hello. I work in the advertising industry, and have been discussing with a prospective client a direct mail piece in support of a prescription product. I understand that you cannot communicate the product name and specify what what malady it treats, but it must be a generic message advising to speak to their healthcare practitioner. My question is that if I were able to source a list of individuals who have reported having this condition, could I send this generic unbranded awareness piece to that identified person?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    234 Views
    No one has replied
  • Jennifer CarrollJ

    528 - On a company website, would we be able to show a picture of a drug along with name, price, quantity and product monograph? Would we be able to also link this drug page to a medical device that it is intended to be used with?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    242 Views
    No one has replied
  • Jennifer CarrollJ

    526 - On an unbranded, consumer-facing, disease state website, it is permissible to discuss differential diagnosis? As in, could you "compare" the symptoms of the website condition with another, similar condition with overlapping symptoms?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    195 Views
    No one has replied
  • Jennifer CarrollJ

    514 - Good morning, Can we disclose the name of the company behind an unbranded website, when such is being asked in a specific tweet? Thanks in advance

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    212 Views
    No one has replied
  • Jennifer CarrollJ

    513 - Section 3(1) of the Food/Drugs Act implies DTC-A is prohibited for products treating Schedule A diseases. Yet, there seems to be many approved DTC-A campaigns for STDs, Arthritis, etc. How is Section 3(1) being implemented in PAAB practice?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    403 Views
    No one has replied
  • Jennifer CarrollJ

    510 - How long does PAAB approval on DTC last? 1 year or 2 years?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    193 Views
    No one has replied
  • Jennifer CarrollJ

    509 - I am wondering how or if section 103.2 of the Natural Health Product Regulations factors in to the review of NHPs as it appears to exempt some NHPs from part of section 3(1) of the Food and Drug Act.

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    222 Views
    No one has replied
  • Jennifer CarrollJ

    499 - We are experienced in submitting DTCI campaigns through regulatory. In these cases, the focus is on the disease and when mentioning drugs, we discuss all treatments indicated for that disease (because there cannot be undue emphasis on any one drug). However, we wish to know about the DTCA of vaccines. For example, are we allowed to talk about the indication/side effects/dosing, etc for one vaccine specifically without mentioning the other vaccines indicated for the prevention of the same disease? In this case, it'll have the "undue emphasis" which is not permissible for schedule F drugs.

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    247 Views
    No one has replied
  • Jennifer CarrollJ

    498 - As a follow-up to Question 299, we would like to ask if it is acceptable to still post such a video on YouTube but make it an unlisted video.... only found when pharmacist's share the URL with a patient who need to learn how to use the product . Thank you for your help !

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    260 Views
    No one has replied
  • Jennifer CarrollJ

    493 - Since DTC advertising is not allowed for products that treat or prevent schedule A diseases, I was wondering whether a product that managers a symptom of a schedule A disease (example: hypoglycemic reactions in diabetes) would have the same restriction?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    171 Views
    No one has replied
  • Jennifer CarrollJ

    470 - Can a Patient Support Program be promoted to consumers? If so, would it be possible to mention features of the support program and link them to the company and the condition(s), with no mention of the products supported by the program?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    238 Views
    No one has replied
  • Jennifer CarrollJ

    464 - Can unbranded patient materials (covering disease state) have a look & feel/creative that is consistent with a DTC campaign?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    353 Views
    No one has replied
  • Jennifer CarrollJ

    463 - Is DTC advertising (i.e. patient support website, journal ads, and waiting room brochures) allowed for a schedule D biologic that is not used to treat or cure a schedule A disease?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    286 Views
    No one has replied
  • Jennifer CarrollJ

    458 - What are PAAB's guidelines or restrictions (if any), regarding boosting posts or promoting a corporate (unbranded) social media page (including Twitter, Facebook, Instagram, LinkedIn)?

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    493 Views
    No one has replied
  • Jennifer CarrollJ

    447 - For consumer surveys which are meant to gather information about current knowledge/attitudes on a certain medical condition and contains no medical information, does it need to be submitted to PAAB along with the rest of the DTCI campaign? We plan to use the survey results as a means to tailor content that addresses some of the knowledge gaps/attitude of consumers. Thank you kindly.

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    187 Views
    No one has replied
  • Jennifer CarrollJ

    443 - For DTCI campaigns, are we allowed to focus on a certain stage of the disease? (For example, mild).

    Watching Ignoring Scheduled Pinned Locked Moved
    1
    0 Votes
    1 Posts
    178 Views
    No one has replied
  • Login

  • Don't have an account? Register

  • Login or register to search.
  • First post
    Last post
0
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups